BUY SAGILITY LIMITED — Manas Jaiswal
byManas JaiswalHorizon: NA (inferred Swing (≤2wk))23 Oct 2026via CNBC Awaaz.
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
MACD above its signal line — bullish momentum
Technicals · macd·23 Oct · today
Sagility Q2 Results: Net profit up 13% on 23% revenue growth; declares dividend
NewsCnbc-Tv18·22 Oct · today
Sagility reported Q2 FY27 consolidated revenue of 20,321 million INR, a 22.5% YoY increase, with adjusted EBITDA of 5,353 million INR (up 23.0% YoY) and adjusted PAT of 3,254 million INR (up 8.1% YoY)
BSE · Company Update·22 Oct · today
Sagility Limited reported consolidated revenue of Rs 20,321 million for Q2 FY27, a 22.5% YoY growth, with an adjusted PAT of Rs 3,254 million, an 8.1% YoY increase.
NSE · Outcome of Board Meeting·22 Oct · today
Sagility Ltd reported Q2 FY27 revenue of ₹20,321 million, a 22.5% YoY growth, and declared an interim dividend of ₹0.15 per equity share.
BSE · Board Meeting·22 Oct · today
Nothing found in this tip’s window yet.
Nothing found in this tip’s window yet.
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on SAGILITY
- BUY — Siddharth Rai Mangala23 Oct 2026 · ~2 weeks · target ₹48 · SL hit
- BUY — J.P. Morgan23 Oct 2026 · ~1 year · target ₹60 · Active
- BUY — Jefferies India23 Oct 2026 · ~1 year · target ₹59 · Active
- BUY — Ansh Jogendra Bhilwar23 Oct 2026 · ~1 year · target ₹50 · Active
- BUY — Osho Krishan, Angel One22 Oct 2026 · ~2 weeks · target ₹47 · Active
More from Manas Jaiswal
- BUY Ajanta Pharma23 Oct 2026 · Same day · target ₹3,425 · SL hit
- BUY Torrent Pharmaceuticals23 Oct 2026 · Same day · target ₹4,725 · SL hit
- BUY Zydus Lifesciences22 Oct 2026 · ~3 months · target ₹1,160 · Active
- BUY IPCA Laboratories22 Oct 2026 · ~2 weeks · target ₹2,000 · Active
- BUY Coforge22 Oct 2026 · Same day · target ₹2,010 · SL hit

